These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31173466)

  • 101. New prospectives on treatment opportunities in RASopathies.
    Gelb BD; Yohe ME; Wolf C; Andelfinger G
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):541-560. PubMed ID: 36533679
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
    Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Biochemical and functional characterization of germ line KRAS mutations.
    Schubbert S; Bollag G; Lyubynska N; Nguyen H; Kratz CP; Zenker M; Niemeyer CM; Molven A; Shannon K
    Mol Cell Biol; 2007 Nov; 27(22):7765-70. PubMed ID: 17875937
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
    Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
    Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
    Carta C; Pantaleoni F; Bocchinfuso G; Stella L; Vasta I; Sarkozy A; Digilio C; Palleschi A; Pizzuti A; Grammatico P; Zampino G; Dallapiccola B; Gelb BD; Tartaglia M
    Am J Hum Genet; 2006 Jul; 79(1):129-35. PubMed ID: 16773572
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I.
    Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M
    Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.
    Cavé H; Caye A; Ghedira N; Capri Y; Pouvreau N; Fillot N; Trimouille A; Vignal C; Fenneteau O; Alembik Y; Alessandri JL; Blanchet P; Boute O; Bouvagnet P; David A; Dieux Coeslier A; Doray B; Dulac O; Drouin-Garraud V; Gérard M; Héron D; Isidor B; Lacombe D; Lyonnet S; Perrin L; Rio M; Roume J; Sauvion S; Toutain A; Vincent-Delorme C; Willems M; Baumann C; Verloes A
    Eur J Hum Genet; 2016 Aug; 24(8):1124-31. PubMed ID: 26757980
    [TBL] [Abstract][Full Text] [Related]  

  • 108. M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras.
    Endo T
    Exp Cell Res; 2020 Dec; 397(1):112342. PubMed ID: 33130177
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The molecular genetics of RASopathies: An update on novel disease genes and new disorders.
    Tartaglia M; Aoki Y; Gelb BD
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):425-439. PubMed ID: 36394128
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.
    Kouz K; Lissewski C; Spranger S; Mitter D; Riess A; Lopez-Gonzalez V; Lüttgen S; Aydin H; von Deimling F; Evers C; Hahn A; Hempel M; Issa U; Kahlert AK; Lieb A; Villavicencio-Lorini P; Ballesta-Martinez MJ; Nampoothiri S; Ovens-Raeder A; Puchmajerová A; Satanovskij R; Seidel H; Unkelbach S; Zabel B; Kutsche K; Zenker M
    Genet Med; 2016 Dec; 18(12):1226-1234. PubMed ID: 27101134
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Characterization of a novel KRAS mutation identified in Noonan syndrome.
    Razzaque MA; Komoike Y; Nishizawa T; Inai K; Furutani M; Higashinakagawa T; Matsuoka R
    Am J Med Genet A; 2012 Mar; 158A(3):524-32. PubMed ID: 22302539
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
    Stellacci E; Carter JN; Pannone L; Stevenson D; Moslehi D; Venanzi S; ; Bernstein JA; Tartaglia M; Martinelli S
    Am J Med Genet A; 2024 Aug; 194(8):e63627. PubMed ID: 38613168
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Further evidence of the importance of RIT1 in Noonan syndrome.
    Bertola DR; Yamamoto GL; Almeida TF; Buscarilli M; Jorge AA; Malaquias AC; Kim CA; Takahashi VN; Passos-Bueno MR; Pereira AC
    Am J Med Genet A; 2014 Nov; 164A(11):2952-7. PubMed ID: 25124994
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Nutritional aspects of Noonan syndrome and Noonan-related disorders.
    da Silva FM; Jorge AA; Malaquias A; da Costa Pereira A; Yamamoto GL; Kim CA; Bertola D
    Am J Med Genet A; 2016 Jun; 170(6):1525-31. PubMed ID: 27038324
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Providing more evidence on LZTR1 variants in Noonan syndrome patients.
    Chinton J; Huckstadt V; Mucciolo M; Lepri F; Novelli A; Gravina LP; Obregon MG
    Am J Med Genet A; 2020 Feb; 182(2):409-414. PubMed ID: 31825158
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
    Aljeaid D; Sanchez AI; Wakefield E; Chadwell SE; Moore N; Prada CE; Zhang W
    Am J Med Genet A; 2019 Apr; 179(4):608-614. PubMed ID: 30762279
    [TBL] [Abstract][Full Text] [Related]  

  • 117. [Noonan syndrome: genetic and clinical update and treatment options].
    Carcavilla A; Suárez-Ortega L; Rodríguez Sánchez A; Gonzalez-Casado I; Ramón-Krauel M; Labarta JI; Quinteiro Gonzalez S; Riaño Galán I; Ezquieta Zubicaray B; López-Siguero JP
    An Pediatr (Engl Ed); 2020 Jul; 93(1):61.e1-61.e14. PubMed ID: 32493603
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Further case of enlarged spinal nerve roots in KRAS-related Noonan syndrome.
    Leoni C; Viscogliosi G; Onesimo R; Verdolotti T; Biagini T; Mazza T; De Luca A; Perri L; Trevisan V; Flex E; Tartaglia M; Zampino G
    Clin Genet; 2023 Jul; 104(1):136-138. PubMed ID: 36757675
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.
    Martinelli S; De Luca A; Stellacci E; Rossi C; Checquolo S; Lepri F; Caputo V; Silvano M; Buscherini F; Consoli F; Ferrara G; Digilio MC; Cavaliere ML; van Hagen JM; Zampino G; van der Burgt I; Ferrero GB; Mazzanti L; Screpanti I; Yntema HG; Nillesen WM; Savarirayan R; Zenker M; Dallapiccola B; Gelb BD; Tartaglia M
    Am J Hum Genet; 2010 Aug; 87(2):250-7. PubMed ID: 20619386
    [TBL] [Abstract][Full Text] [Related]  

  • 120. RASopathies.
    Jafry M; Sidbury R
    Clin Dermatol; 2020; 38(4):455-461. PubMed ID: 32972603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.